Announcement on the Subsidiary Obtaining New Veterinary Drug Registration Certificate
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on the Subsidiary Obtaining New Veterinary Drug Registration Certificate
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-the-subsidiary-obtaining-new-veterinary-drug-registration-certificate-1
Release
Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Hisun Pharmaceutical
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on the Wholly-Owned Subsidiary Receiving the CEP Certificate for Everolimus API
- Announcement on Progress in Public Transfer of 100% Equity in the Wholly-owned Subsidiary Zhejiang Pharmaceutical Industry Corp., Ltd.
- Announcement on Wholly-owned Subsidiary's Passing GMP Compliance Inspection for Drugs
- Announcement on Resolutions of the 9th Meeting of the 10th Board of Directors
Later from Zhejiang Hisun Pharmaceutical
- Announcement on HS387 Tablets Obtaining the U.S. FDA Approval for Clinical Trials of a New Drug
- Announcement on Obtaining the Notice on Approval of Drug Supplement Application
- Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
- Indicative Announcement on Proposed Transfer of Shares by Shareholders Holding over 5% Shares by Agreement through Public Solicitation and Change of Control Right
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Zhejiang Hisun Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Hisun Pharmaceutical